Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol- 13-acetate-induced interferon-γ-mediated skin inflammation

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 1, 2012, Pages 125-133

  Hsieh, Chia Yuan ^a   Chen, Chia Ling ^a   Tsai, Cheng Chieh ^a,b   Huang, Wei Ching ^a   Tseng, Po Chun ^a   Lin, Yee Shin ^a   Chen, Shun Hua ^a   Wong, Tak Wah ^a   Choi, Pui Ching ^a   Lin, Chiou Feng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

6 BROMOINDIRUBIN 3' OXIME; CD3 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; GLYCOGEN SYNTHASE KINASE 3; INDIRUBIN; INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; PHORBOL 13 ACETATE 12 MYRISTATE; SHORT HAIRPIN RNA; STAT1 PROTEIN; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; ENZYME ACTIVATION; ENZYME INHIBITION; EPIDERMIS CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKIN EDEMA; SKIN INFLAMMATION; T LYMPHOCYTE;

ANIMALS; CELL LINE; DERMATITIS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIMES; RECEPTORS, INTERFERON; TETRADECANOYLPHORBOL ACETATE;

EID: 84866327980     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.194100     Document Type: Article

References (40)

1. Abdallah MA, Abdel-Hamid MF, Kotb AM, and Mabrouk EA (2009) Serum interfer-on-γ is a psoriasis severity and prognostic marker. Cutis 84:163-168.
2. Arakura F, Hida S, Ichikawa E, Yajima C, Nakajima S, Saida T, and Taki S (2007) Genetic control directed toward spontaneous IFN-α/IFN-β responses and downstream IFN-γ expression influences the pathogenesis of a murine psoriasis-like skin disease. J Immunol 179:3249-3257.
3. Bach EA, Aguet M, and Schreiber RD (1997) The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-591. (Pubitemid 27169292)
4. Beurel E, Michalek SM, and Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31:24-31.
5. Beurel E, Yeh WI, Michalek SM, Harrington LE, and Jope RS (2011) Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J Immunol 186:1391-1398.
6. Cojocaru M, Cojocaru IM, and Silosi I (2010) Multiple autoimmune syndrome. Maedica (Buchar) 5:132-134.
7. De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T, and Iyer S (2005) Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J Invest Dermatol 125:473-481.
8. Donnelly RP, Freeman SL, and Hayes MP (1995) Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J Immunol 155:1420-1427.
9. Fry L and Baker BS (2007) Triggering psoriasis: the role of infections and medications. Clin Dermatol 25:606-615. (Pubitemid 350087607)
10. Gao J, Morrison DC, Parmely TJ, Russell SW, and Murphy WJ (1997) An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J Biol Chem 272:1226-1230. (Pubitemid 27034621)
11. Grandjean EM and Aubry JM (2009) Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23:397-418.
12. Hampton PJ, Jans R, Flockhart RJ, Parker G, and Reynolds NJ (2012) Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2). J Cell Physiol 227:1529-1537.
13. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, and Ivashkiv LB (2006) IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24:563-574. (Pubitemid 43728157)
14. Hwang ES, Hong JH, and Glimcher LH (2005) IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J Exp Med 202:1289-1300.
15. Jablonska J, Leschner S, Westphal K, Lienenklaus S, and Weiss S (2010) Neutrophils responsive to endogenous IFN-γ regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120:1151-1164.
16. Kai JI, Huang WC, Tsai CC, Chang WT, Chen CL, and Lin CF (2010) Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis. J Cell Biochem 111:1522-1530.
17. Knijff EM, Kupka RW, Ruwhof C, Breunis MN, Prens EP, Nolen WA, and Drexhage HA (2005) Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis. Bipolar Disord 7:388-389. (Pubitemid 41065241)
18. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, Dooley LT, Lebwohl M, and CNTO 1275 Psoriasis Study Group (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356:580-592. (Pubitemid 46220818)
19. Kupper TS and Fuhlbrigge RC (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4:211-222. (Pubitemid 38339087)
20. Lin CF, Tsai CC, Huang WC, Wang CY, Tseng HC, Wang Y, Kai JI, Wang SW, and Cheng YL (2008) IFN-γ synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J Cell Biochem 105:746-755.
21. Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, and Russell SW (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-γ and lipopolysaccharide. J Biol Chem 268:1908-1913. (Pubitemid 23033592)
22. Nestle FO, Kaplan DH, and Barker J (2009) Psoriasis. N Engl J Med 361:496-509.
23. Oberg F, Wu S, Bahram F, Nilsson K, and Larsson LG (2001) Cytokine-induced restoration of differentiation and cell cycle arrest in v-Myc transformed U-937 monoblasts correlates with reduced Myc activity. Leukemia 15:217-227. (Pubitemid 32175453)
24. Park SY, Gupta D, Hurwich R, Kim CH, and Dziarski R (2011) Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses. J Immunol 187:5813-5823.
25. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375-386.
26. Ramana CV, Gil MP, Schreiber RD, and Stark GR (2002) Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol 23:96-101. (Pubitemid 34310151)
27. Saha B, Jyothi Prasanna S, Chandrasekar B, and Nandi D (2010) Gene modulation and immunoregulatory roles of interferon γ. Cytokine 50:1-14.
28. + cells and drives IFN-γ-dependent epidermal hyperplasia. J Immunol 186:5435-5442.
29. Schoenborn JR and Wilson CB (2007) Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol 96:41-101. (Pubitemid 350018717)
30. Schön MP and Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899-1912. (Pubitemid 40627816)
31. Schroder K, Hertzog PJ, Ravasi T, and Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-189. (Pubitemid 38174573)
32. Steinman L (2010) Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 11:41-44.
33. H1) lymphocytes and serum IFN-γ levels in psoriatic patients. Immunol Lett 86:277-280.
34. Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, and Iizuka H (2010) Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35:645-649.
35. Tsai CC, Huang WC, Chen CL, Hsieh CY, Lin YS, Chen SH, Yang KC, and Lin CF (2011) Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-mediated immune hepatic injury. J Immunol 187:3867-3877.
36. Tsai CC, Kai JI, Huang WC, Wang CY, Wang Y, Chen CL, Fang YT, Lin YS, Anderson R, Chen SH, et al. (2009) Glycogen synthase kinase-3β facilitates IFN-γ-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J Immunol 183:856-864.
37. Wang H, Brown J, and Martin M (2011) Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53:130-140.
38. Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener PA, et al. (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS One 3:e2737.
39. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, Gonzalez J, Krueger JG, and Lowes MA (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129:79-88.
40. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, and Ouyang W (2007) Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-651. (Pubitemid 46232884)